CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.2300
-0.0371 (-13.89%)
At close: Nov 20, 2026, 4:00 PM EST
0.2400
+0.0100 (4.35%)
After-hours: Nov 20, 2026, 7:55 PM EST
CDT Equity Market Cap
CDT Equity has a market cap or net worth of $12.93 thousand as of November 20, 2026. It is the 51,842nd most valuable company in the world and the 7,723rd biggest in the United States. Its market cap has decreased by 99.54% in one year.
Market Cap
12.93K
Enterprise Value
-500.07K
1-Year Change
-99.54%
Global Rank
Country Rank
#7,723 United States
Category
ChartMarket Cap Chart
Since March 28, 2022, CDT Equity's market cap has decreased from $28.40B to $12.93K, a decrease of -100.00%. That is a compound annual growth rate of -95.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 12.93K | -99.38% |
| Dec 31, 2025 | 2.08M | -99.99% |
| Dec 31, 2024 | 24.50B | -98.49% |
| Dec 29, 2023 | 1.63T | 5,448.78% |
| Dec 30, 2022 | 29.29B | 3.12% |
| Mar 28, 2022 | 28.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 951.26K |
| Bone Biologics | 944.19K |
| Matinas BioPharma Holdings | 765.00K |
| Oragenics | 717.85K |
| GeoVax Labs | 682.04K |
| SciSparc | 451.55K |
| Valion Bio | 426.13K |
| Silexion Therapeutics | 317.42K |